BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 26036690)

  • 1. Febuxostat ameliorates doxorubicin-induced cardiotoxicity in rats.
    Krishnamurthy B; Rani N; Bharti S; Golechha M; Bhatia J; Nag TC; Ray R; Arava S; Arya DS
    Chem Biol Interact; 2015 Jul; 237():96-103. PubMed ID: 26036690
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Doxorubicin treatment in vivo causes cytochrome C release and cardiomyocyte apoptosis, as well as increased mitochondrial efficiency, superoxide dismutase activity, and Bcl-2:Bax ratio.
    Childs AC; Phaneuf SL; Dirks AJ; Phillips T; Leeuwenburgh C
    Cancer Res; 2002 Aug; 62(16):4592-8. PubMed ID: 12183413
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic effects of ivabradine on hemodynamic parameters and cardiotoxicity induced by doxorubicin treatment in rat.
    Colak MC; Parlakpinar H; Tasdemir S; Samdanci E; Kose E; Polat A; Sarihan E; Acet A
    Hum Exp Toxicol; 2012 Sep; 31(9):945-54. PubMed ID: 22354086
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Baicalein alleviates doxorubicin-induced cardiotoxicity via suppression of myocardial oxidative stress and apoptosis in mice.
    Sahu BD; Kumar JM; Kuncha M; Borkar RM; Srinivas R; Sistla R
    Life Sci; 2016 Jan; 144():8-18. PubMed ID: 26606860
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antioxidants and tumor necrosis factor alpha-inhibiting activity of sesame oil against doxorubicin-induced cardiotoxicity.
    Saleem MT; Chetty MC; Kavimani S
    Ther Adv Cardiovasc Dis; 2014 Feb; 8(1):4-11. PubMed ID: 24441175
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Carvedilol prevents doxorubicin-induced free radical release and apoptosis in cardiomyocytes in vitro.
    Spallarossa P; Garibaldi S; Altieri P; Fabbi P; Manca V; Nasti S; Rossettin P; Ghigliotti G; Ballestrero A; Patrone F; Barsotti A; Brunelli C
    J Mol Cell Cardiol; 2004 Oct; 37(4):837-46. PubMed ID: 15380674
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Febuxostat ameliorates diabetic renal injury in a streptozotocin-induced diabetic rat model.
    Lee HJ; Jeong KH; Kim YG; Moon JY; Lee SH; Ihm CG; Sung JY; Lee TW
    Am J Nephrol; 2014; 40(1):56-63. PubMed ID: 25034030
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chrysin alleviates acute doxorubicin cardiotoxicity in rats via suppression of oxidative stress, inflammation and apoptosis.
    Mantawy EM; El-Bakly WM; Esmat A; Badr AM; El-Demerdash E
    Eur J Pharmacol; 2014 Apr; 728():107-18. PubMed ID: 24509133
    [TBL] [Abstract][Full Text] [Related]  

  • 9. General oxidative stress during doxorubicin-induced cardiotoxicity in rats: absence of cardioprotection and low antioxidant efficiency of alpha-lipoic acid.
    Ghibu S; Delemasure S; Richard C; Guilland JC; Martin L; Gambert S; Rochette L; Vergely C
    Biochimie; 2012 Apr; 94(4):932-9. PubMed ID: 21396425
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Doxorubicin mediated cardiotoxicity in rats: protective role of felodipine on cardiac indices.
    Gandhi H; Patel VB; Mistry N; Patni N; Nandania J; Balaraman R
    Environ Toxicol Pharmacol; 2013 Nov; 36(3):787-95. PubMed ID: 23958971
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Liraglutide ameliorates cardiotoxicity induced by doxorubicin in rats through the Akt/GSK-3β signaling pathway.
    Abbas NAT; Kabil SL
    Naunyn Schmiedebergs Arch Pharmacol; 2017 Nov; 390(11):1145-1153. PubMed ID: 28780599
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiotoxicity of doxorubicin/paclitaxel combination in rats: effect of sequence and timing of administration.
    Saad SY; Najjar TA; Alashari M
    J Biochem Mol Toxicol; 2004; 18(2):78-86. PubMed ID: 15122649
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protective effects of caffeic acid phenethyl ester on doxorubicin-induced cardiotoxicity in rats.
    Fadillioglu E; Oztas E; Erdogan H; Yagmurca M; Sogut S; Ucar M; Irmak MK
    J Appl Toxicol; 2004; 24(1):47-52. PubMed ID: 14745846
    [TBL] [Abstract][Full Text] [Related]  

  • 14. β-caryophyllene, a dietary phytocannabinoid attenuates oxidative stress, inflammation, apoptosis and prevents structural alterations of the myocardium against doxorubicin-induced acute cardiotoxicity in rats: An in vitro and in vivo study.
    Al-Taee H; Azimullah S; Meeran MFN; Alaraj Almheiri MK; Al Jasmi RA; Tariq S; Ab Khan M; Adeghate E; Ojha S
    Eur J Pharmacol; 2019 Sep; 858():172467. PubMed ID: 31216443
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Allicin ameliorates doxorubicin-induced cardiotoxicity in rats via suppression of oxidative stress, inflammation and apoptosis.
    Abdel-Daim MM; Kilany OE; Khalifa HA; Ahmed AAM
    Cancer Chemother Pharmacol; 2017 Oct; 80(4):745-753. PubMed ID: 28785995
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epigallocatechin-3-gallate pretreatment attenuates doxorubicin-induced cardiotoxicity in rats: A mechanistic study.
    Saeed NM; El-Naga RN; El-Bakly WM; Abdel-Rahman HM; Salah ElDin RA; El-Demerdash E
    Biochem Pharmacol; 2015 Jun; 95(3):145-55. PubMed ID: 25701654
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preventive effects of ellagic acid against doxorubicin-induced cardio-toxicity in mice.
    Lin MC; Yin MC
    Cardiovasc Toxicol; 2013 Sep; 13(3):185-93. PubMed ID: 23322372
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardioprotective effect of metformin against doxorubicin cardiotoxicity in rats.
    Argun M; Üzüm K; Sönmez MF; Özyurt A; Derya K; Çilenk KT; Unalmış S; Pamukcu Ö; Baykan A; Narin F; Elmalı F; Narin N
    Anatol J Cardiol; 2016 Apr; 16(4):234-41. PubMed ID: 26642465
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sesamin ameliorates doxorubicin-induced cardiotoxicity: involvement of Sirt1 and Mn-SOD pathway.
    Su S; Li Q; Liu Y; Xiong C; Li J; Zhang R; Niu Y; Zhao L; Wang Y; Guo H
    Toxicol Lett; 2014 Jan; 224(2):257-63. PubMed ID: 24211423
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oxidative stress and myocardial gene alterations associated with Doxorubicin-induced cardiotoxicity in rats persist for 2 months after treatment cessation.
    Richard C; Ghibu S; Delemasure-Chalumeau S; Guilland JC; Des Rosiers C; Zeller M; Cottin Y; Rochette L; Vergely C
    J Pharmacol Exp Ther; 2011 Dec; 339(3):807-14. PubMed ID: 21934029
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.